Biblio

Export 644 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is N  [Clear All Filters]
2021
K. Kawamura, Miyajima, M., Nakajima, M., Kanai, M., Motoi, Y., Nojiri, S., Akiba, C., Ogino, I., Xu, H., Kamohara, C., Yamada, S., Karagiozov, K., Ikeuchi, T., Kondo, A., and Arai, H., “Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 83, no. 1, pp. 179-190, 2021.
K. Kawamura, Miyajima, M., Nakajima, M., Kanai, M., Motoi, Y., Nojiri, S., Akiba, C., Ogino, I., Xu, H., Kamohara, C., Yamada, S., Karagiozov, K., Ikeuchi, T., Kondo, A., and Arai, H., “Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 83, no. 1, pp. 179-190, 2021.
A. A. Harb, Chen, R. J., Chase, H. S., Natarajan, K., and Noble, J. M., “Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave.”, J Alzheimers Dis, vol. 81, no. 2, pp. 679-690, 2021.
A. A. Harb, Chen, R. J., Chase, H. S., Natarajan, K., and Noble, J. M., “Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave.”, J Alzheimers Dis, vol. 81, no. 2, pp. 679-690, 2021.
F. Yu, Vock, D. M., Zhang, L., Salisbury, D., Nelson, N. W., Chow, L. S., Smith, G., Barclay, T. R., Dysken, M., and Wyman, J. F., “Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial.”, J Alzheimers Dis, vol. 80, no. 1, pp. 233-244, 2021.
J. Cummings, Schwartz, G. G., Nicholls, S. J., Khan, A., Halliday, C., Toth, P. P., Sweeney, M., Johansson, J. O., Wong, N. C. W., Kulikowski, E., Kalantar-Zadeh, K., Lebioda, K., Ginsberg, H. N., Winblad, B., Zetterberg, H., and Ray, K. K., “Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1703-1715, 2021.
Y. Yamada, Shinkawa, K., Kobayashi, M., Caggiano, V., Nemoto, M., Nemoto, K., and Arai, T., “Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 84, no. 1, pp. 315-327, 2021.
Y. Yamada, Shinkawa, K., Kobayashi, M., Caggiano, V., Nemoto, M., Nemoto, K., and Arai, T., “Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 84, no. 1, pp. 315-327, 2021.
A. Subotic, McCreary, C. R., Saad, F., Nguyen, A., Alvarez-Veronesi, A., Zwiers, A. M., Charlton, A., Beaudin, A. E., Ismail, Z., G Pike, B., and Smith, E. E., “Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1663-1671, 2021.
M. Waller, Buckley, R. F., Masters, C. L., Nona, F. R., Eades, S., and Dobson, A. J., “Deaths with Dementia in Indigenous and Non-Indigenous Australians: A Nationwide Study.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1589-1599, 2021.
S. Toniolo, Scarioni, M., Di Lorenzo, F., Hort, J., Georges, J., Tomic, S., Nobili, F., and Frederiksen, K. Steen, “Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care.”, J Alzheimers Dis, vol. 82, no. 3, pp. 883-898, 2021.
K. H. Elverman, Paitel, E. R., Figueroa, C. M., McKindles, R. J., and Nielson, K. A., “Event-Related Potentials, Inhibition, and Risk for Alzheimer's Disease Among Cognitively Intact Elders.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1413-1428, 2021.
K. R. Kadey, Woodard, J. L., Moll, A. C., Nielson, K. A., J Smith, C., Durgerian, S., and Rao, S. M., “Five-Year Change in Body Mass Index Predicts Conversion to Mild Cognitive Impairment or Dementia Only in APOE ɛ4 Allele Carriers.”, J Alzheimers Dis, vol. 81, no. 1, pp. 189-199, 2021.
S. Toniolo, Di Lorenzo, F., Scarioni, M., Frederiksen, K. Steen, and Nobili, F., “Is the Frontal Lobe the Primary Target of SARS-CoV-2?”, J Alzheimers Dis, vol. 81, no. 1, pp. 75-81, 2021.
J. Won, Callow, D. D., Pena, G. S., Jordan, L. S., Arnold-Nedimala, N. A., Nielson, K. A., and J Smith, C., “Hippocampal Functional Connectivity and Memory Performance After Exercise Intervention in Older Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1015-1031, 2021.
M. Dhaynaut, Sprugnoli, G., Cappon, D., Macone, J., Sanchez, J. S., Normandin, M., Guehl, N., Koch, G., Paciorek, R., Connor, A., Press, D., Johnson, K., Pascual-Leone, A., El-Fakhri, G., and Santarnecchi, E., “Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer's Disease: A Case Series.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1667-1676, 2021.
N. Jouini, Saied, Z., Ben Sassi, S., Nebli, F., Messaoud, T., Hentati, F., and Belal, S., “Impacts of Iron Metabolism Dysregulation on Alzheimer's Disease.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1439-1450, 2021.
Z. P. Qureshi, Thiel, E., Nelson, J., and Khandker, R., “Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1679-1690, 2021.
J. P. Pandey, Namboodiri, A. M., Nietert, P. J., Barnes, L. L., and Bennett, D. A., “Inhibitory Fcγ Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 84, no. 3, pp. 965-968, 2021.
J. P. Pandey, Namboodiri, A. M., Nietert, P. J., Barnes, L. L., and Bennett, D. A., “Inhibitory Fcγ Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 84, no. 3, pp. 965-968, 2021.
N. Hin, Newman, M., Pederson, S., and Lardelli, M., “Iron Responsive Element-Mediated Responses to Iron Dyshomeostasis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 84, no. 4, pp. 1597-1630, 2021.
E. Zupanic, von Euler, M., Winblad, B., Xu, H., Secnik, J., Kramberger, M. Gregoric, Religa, D., Norrving, B., and Garcia-Ptacek, S., “Mortality After Ischemic Stroke in Patients with Alzheimer's Disease Dementia and Other Dementia Disorders.”, J Alzheimers Dis, vol. 81, no. 3, pp. 1253-1261, 2021.
S. Nakamura, Yomota, S., Ito, H., Akinaga, N., Hori, A., Chinomi, K., Suzuki, H., Uchida, K., and Asada, T., “A Novel Cognitive Function Scale Using Functional Near-Infrared Spectroscopy for Evaluating Cognitive Dysfunction.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1579-1588, 2021.
K. Deniz, Ho, C. C. G., Malphrus, K. G., Reddy, J. S., Nguyen, T., Carnwath, T. P., Crook, J. E., Lucas, J. A., Graff-Radford, N. R., Carrasquillo, M. M., and Ertekin-Taner, N., “Plasma Biomarkers of Alzheimer's Disease in African Americans.”, J Alzheimers Dis, vol. 79, no. 1, pp. 323-334, 2021.
W. Huang, Zeng, F., Gu, Y., Jiang, M., Zhang, X., Yan, X., Kadowaki, T., Mizutani, S., Kashiwazaki, H., Ni, J., and Wu, Z., “Porphyromonas Gingivalis Infection Induces Synaptic Failure via Increased IL-1β Production in Leptomeningeal Cells.”, J Alzheimers Dis, vol. 83, no. 2, pp. 665-681, 2021.

Pages